Cytonome Concludes Exclusive Sales Partnership Agreement with Inabata

Cytonome/ST, LLC and Inabata & Co., Ltd. and have concluded an exclusive sales partnership agreement for Cytonome’s proprietary GigaSort® Technology in Japan.

The GigaSort Platform is an application specific laser-based cell sorter that allows the identification, characterization, and isolation of highly purified cell populations. Due to its low pressure parallel microfluidic channel design, the GMP compliant GigaSort Platform provides high throughput processing while remaining gentle on cells. A fully enclosed, single use, fluidic set that contains a microfluidic chip solves the safety and contamination problems that have plagued therapeutic cell sorting applications using conventional aerosol-based cell sorting technologies, thus making the GigaSort Platform a strong candidate solution for high performance cell therapy applications such as regenerative medicine using iPS cells and CAR-T therapy.

Leave a Reply